An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers

• June Y. Hou,
• Jason D. Wright,
• Vuthinun Achariyapota

Affiliations

June Y. Hou

Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, USA

Jason D. Wright

Columbia University Vagelos College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, USA

Vuthinun Achariyapota

Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand; Corresponding author at: Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, 2 Wanglang Road, Siriraj, Bangkok Noi, Bangkok 10700, Thailand.